We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSEE
9876
VSee Health
VSEE
$4.38M
$1K ﹤0.01%
+100
New +$994
SAIHW
9877
SAIHEAT Ltd Warrant
SAIHW
$62.6K
$1K ﹤0.01%
+1,384
New +$414
VEEAW
9878
Veea Inc Warrant
VEEAW
$1K ﹤0.01%
+1,425
New +$736
GRCE
9879
Grace Therapeutics
GRCE
$33.8M
$1K ﹤0.01%
+198
New +$1.41K
AEVAW
9880
DELISTED
Aeva Technologies Warrants
AEVAW
$1K ﹤0.01%
1,163
-3,517
-75% -$3.33K
ENZ
9881
DELISTED
Enzo Biochem, Inc.
ENZ
$1K ﹤0.01%
425
-2,779
-87% -$8.92K
RDW.WS
9882
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
$1K ﹤0.01%
333
-376
-53% -$611
SYRS
9883
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
50
-2,616
-98% -$46.8K
PNST
9884
DELISTED
Pinstripes Holdings, Inc.
PNST
$1K ﹤0.01%
+100
New +$992
PLMJ
9885
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$1K ﹤0.01%
129
+100
+345% +$967
TETE
9886
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
$1K ﹤0.01%
+100
New +$993
IVCB
9887
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$1K ﹤0.01%
+71
New +$706
NVACW
9888
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$1K ﹤0.01%
+4,645
New +$824
BOCN
9889
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
$1K ﹤0.01%
+100
New +$987
INNO
9890
DELISTED
Harbor Disruptive Innovation ETF
INNO
$1K ﹤0.01%
+51
New +$841
WEL.WS
9891
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$1K ﹤0.01%
+1,600
New +$572
MCAGR
9892
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$1K ﹤0.01%
+4,000
New +$1.23K
NPAB
9893
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
$1K ﹤0.01%
+90
New +$890
ONYXW
9894
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1K ﹤0.01%
+1,700
New +$586
SURGW
9895
DELISTED
SurgePays, Inc. Warrant
SURGW
$1K ﹤0.01%
1,608
-8,076
-83% -$6.1K
PHGE.U
9896
DELISTED
BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock
PHGE.U
$1K ﹤0.01%
25
NTBL
9897
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$1K ﹤0.01%
12
-55
-82% -$2.8K
GTACW
9898
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$1K ﹤0.01%
+2,400
New +$1.05K
MOHR
9899
DELISTED
Mohr Growth ETF
MOHR
$1K ﹤0.01%
49
-50
-51% -$1.16K
TCOA.U
9900
DELISTED
Zalatoris Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one redeemable public warrant
TCOA.U
$1K ﹤0.01%
+100
New +$994

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.